Μg Of Gonadorelin Research Articles

242 Comparison of GnRH administration day in the 7&7 Synch versus 8&6 Synch Protocol for fixed-timed artificial insemination in beef heifers

Abstract The research aimed to investigate the impact of reducing the time interval for progesterone exposure on the ovulatory follicle just before performing fixed-timed artificial insemination (FTAI). This was achieved by adjusting the timing of administering a gonadotropin-releasing hormone agonist (GnRH; specifically, 100 µg gonadorelin, known as Cystorelin). The study assessed the effectiveness of two estrous synchronization protocols, the “7 & 7 Synch” and a modified protocol, by examining estrus expression (EE) and the resulting pregnancy rates (PR) following FTAI. The research utilized frozen conventional Angus semen from Select Sires, Inc. (Plain City, OH), and involved 66 Angus-cross heifers from the beef cattle research unit near Fayetteville at the University of Arkansas. To ensure consistency, the heifers were divided into two treatment groups based on their cyclicity status (CYC) and age. CYC status was determined by assessing a reproductive tract score (RTS) 1 wk before the synchronization process. RTS scores ranged from 1 to 5, with RTS 1-3 indicating pre- or peripubertal status and scores of 4 and 5 indicating cycling. Heifers with an RTS of 1 and 2 were excluded from the study before synchronization commenced. Both treatment groups involved the insertion of a controlled internal drug-releasing device (CIDR; specifically, Eazi-breed, containing 1.38 g of progesterone) into the vagina on d -14. Simultaneously, a prostaglandin F2α analogue (PGF; 500 µg cloprostenol sodium, known as Synchsure) was administered. In the first treatment group (7&7), GnRH was administered on d -7, while in the second group (8&6), GnRH was given on d -6. In both cases, PGF was administered on d 0 when the CIDR was removed, precisely 72 ± 1 h before FTAI, along with another dose of GnRH. Estrus expression (EE) was assessed during FTAI by examining Estrotect patches (Rockway Inc., Spring Valley, WI). EE was considered present when a patch had 50% or more of its color rubbed off, and it was deemed absent when less than 50% of the color had worn off. Pregnancy rates (PR) were determined through ultrasound examination on d 55. EE and PR were analyzed by treatment using the GLIMMIX procedure on SAS 9.4 (SAS Institute Inc., Cary, NC). Statistical differences were declared at α ≤ 0.05 and tendencies declared between 0.05 < P ≤ 0.1. Heifers on the 8&6-d protocol had greater rectal temperatures at breeding compared with 7&7-d heifers (P < 0.0001). AI pregnancy rates were greater in heifers on the 8&6-d protocol compared with the heifers on 7&7-d protocol (P = 0.625) with average pregnancy rates of 39.4% and 30.3%, respectively. Overall, pregnancy rate was greater as well for the 8&6-d heifers compared with the 7&7-d heifers (P = 0.044), with mean overall pregnancy rates of 78.8% and 54.5%, respectively.

Evaluation of later timepoints for fixed-time artificial insemination of beef heifers and cows when using sex-sorted semen

Two experiments were designed to evaluate later timepoints for fixed-time artificial insemination (FTAI) of beef heifers and cows, with the hypothesis that use of a later timepoint would allow a greater proportion of animals to express estrus prior to FTAI and result in greater conception rates among estrous females inseminated with sex-sorted semen. In Experiment 1, estrus was synchronized for 1640 heifers using the 14 d CIDR-PG protocol: insertion of an intravaginal progesterone-releasing insert (CIDR; 1.38 g progesterone) on Day −33 and removal on Day −19, and administration of prostaglandin F2α (PG; 500 μg cloprostenol sodium) on Day −3. Heifers were inseminated at one of three FTAI timepoints: 66 h, 70 h, or 74 h after PG administration. In Experiment 2, estrus was synchronized for 414 beef cows using the 7 & 7 Synch protocol: administration of PG coincident with CIDR insertion on Day −17, gonadotropin-releasing hormone (GnRH; 100 μg gonadorelin) on Day −10, and PG coincident with CIDR removal on Day −3. Cows were inseminated at one of two FTAI timepoints: 66 h or 72 h after PG administration. In both experiments, only animals that expressed estrus prior to FTAI were inseminated with sex-sorted semen. In Experiment 1, the proportion of heifers that expressed estrus prior to FTAI (66 h: 62 %; 70 h: 67 %; 74 h: 71 %) was greater when FTAI was performed at 74 h versus 66 h (P = 0.0097); however, conception rate of heifers that expressed estrus and were serviced with sex-sorted semen did not differ among treatments (P = 0.67; 66 h: 56 %; 70 h: 53 %; 74 h: 53 %). In Experiment 2, the proportion of cows expressing estrus prior to FTAI did not differ between treatments (P = 0.30; 66 h: 71 %; 72 h: 76 %). Additionally, conception rate of estrous cows inseminated with sex-sorted semen did not differ between treatments (P = 0.24; 66 h: 45 %; 72 h: 40 %). These results indicate that performing FTAI later following the 14 d CIDR-PG protocol increases the proportion of heifers that express estrus and are serviced with sex-sorted semen but does not improve conception rates. Later timing of FTAI following the 7 & 7 Synch protocol was not observed to increase the proportion of cows expressing estrus prior to FTAI or improve conception rates among estrous cows inseminated with sex-sorted semen. Together, these results provide further insight into optimal timing of FTAI when using sex-sorted semen.

Influence of an eCG administration on puerperal involution and fertility in Simmentaler cows

In the literature, various methods aiming for a promotion of uterine involution and ovarian function in post-partum dairy cattle have been described. Recently, successful use of equine choriongonadotropin (eCG) in this context has been repeatedly reported, while other studies have failed to demonstrate positive effects of eCG administration on puerperal involution in cows. Due to the contradictory results described in the literature, the aim of this field study was to verify whether the administration of eCG on day 10 post-partum exerts a positive effect on uterine involution, ovarian activity and fertility indices in Simmental cows. In nine dairy farms, 205 Simmental cows were divided by lot into three groups: Group 1 animals received 500 I.U. eCG, group 2 received 50 µg gonadorelin, and group 3 animals received 250 mg butafosfan and 125 µg cyanocobalamin (control group). Treatment was administered on day 10 post-partum in each case. The animals were examined clinically and ultrasonographically on the 10th, 25th and 42nd day post-partum and the time to insemination and pregnancy were recorded. Group comparison with respect to the recorded parameters was initially performed without considering confounding factors by analysis of variance. In the second step, potential influencing variables (lactation, milk yield, change in backfat thickness, retentio secundarium and serverity of the obstetric intervention) were taken into account, as well as the combination of the random factors "farm" and "individual animal within the farm". The administration of eCG exhibited no significant effect on uterine involution, however, the cervical involution was influenced significantly. In the group of cows with eCG treatment, ovarian cysts were detected significantly more frequently on day 25 post-partum (p=0.04). This difference did not persist on the 42nd day post-partum. Neither voluntary waiting period nor the days open were significantly shortened by eCG administration. Lactation number showed a significant effect on uterine involution. Heifers exhibited more rapid involution by day 42 post-partum than cows. Administration of eCG in Simmentaler cows at day 10 post-partum showed no positive effect. The use of eCG in early puerperium to promote fertility in the cow should be avoided.

PSIII-6 Evaluation of Later Timepoints for Fixed-Time Artificial Insemination of Beef Heifers When Using sex-Sorted Semen Following the 14-d Cidr®-PG Protocol

Abstract An experiment was designed to evaluate later timepoints for fixed-time artificial insemination (FTAI) of beef heifers, with the hypothesis that use of a later timepoint would allow a greater proportion of heifers to express estrus prior to FTAI and result in greater conception rates among estrous heifers inseminated with sex-sorted semen. Estrus was synchronized using the 14-d CIDR®-PG protocol (1.38 g progesterone CIDR intravaginally inserted Day -33 and removed Day -19, PGF2a; 500 µg cloprostenol administered Day -3) for 1640 heifers in 7 locations. Heifers were blocked by reproductive tract score and body weight and randomly assigned to one of three FTAI timepoints: 66 ± 2 h, 70 ± 2 h, or 74 ± 2 h after PGF2a administration. Estrus detection aids (Estrotect) were applied at PGF2a administration, with activation recorded at FTAI. Heifers that expressed estrus prior to FTAI were serviced with sex-sorted semen (SexedULTRA 4M™). Heifers that failed to express estrus were serviced with conventional semen and administered gonadotropin-releasing hormone (GnRH; 100 µg gonadorelin). The proportion of heifers that expressed estrus by FTAI (66 h: 63%; 70 h: 68%; 74 h: 72%) was greater at 74 h versus 66 h (P < 0.01). Conception rates did not differ significantly between treatments among heifers that expressed estrus and were serviced with sex-sorted semen (66 h: 55%; 70 h: 53%; 74 h: 52%). Among heifers that failed to express estrus and were serviced with conventional semen, conception rates were greater (P = 0.02) when FTAI was performed at 66 h versus 70 h (66 h: 39%; 70 h: 26%; 74 h: 32%). Results indicate that performing FTAI later following the 14-d CIDR®-PG protocol increases the proportion of heifers that express estrus and are serviced with sex-sorted semen, but does not improve conception rates of estrous heifers inseminated at later timepoints.

PSI-5 Comparison of 7&7 Synch and 7-day Co-Synch + Cidr Protocols in a Fixed-Time ai System on Beef Cows Using Y-Sorted sex-Selected Semen

Abstract The 7&7 Synch and the 7-day CO-Synch+CIDR fixed-time estrous synchronization protocols were compared among mature and two-year-old lactating postpartum Angus and SimAngus cows (n=201). Mature (n=63) and two-year-old (n=36) cows treated with the 7&7 Synch received an injection of prostaglandin F2α (PGF; 25 mg dinoprost tromethamine) at the same time as insertion of an intravaginal progesterone-releasing insert (CIDR; 1.38g progesterone) on Day -17, gonadotrophin-releasing hormone (GnRH; 100 μg gonadorelin) on Day -10, and PGF at time of CIDR removal on Day -3. Mature (n=65) and two-year-old (n=37) cows in the 7-day CO-Synch+CIDR groups received an injection of GnRH on Day -10 that coincided with CIDR insertion and received PGF at the time of CIDR removal on Day -3. Fixed-timed AI (FTAI) by a single technician using Y-chromosome-bearing sex-sorted semen (4x106 sperm/unit of SexedULTRA 4M) from one of two Charolais bulls occurred on Day 0, 70 hours after PGF injection. Seven days later bulls were pastured with cows for the remainder of the breeding season. Transrectal ultrasound was performed 77-83 days after AI and fetal size was used to differentiate AI and natural service pregnancies. Within the mature cows and two-year-old age groups, the GLIMMIX procedure in SAS was used to compare FTAI and breeding season pregnancy rates with estrous synchronization treatment and sire as main effects. No differences (P=0.41) were observed amongst mature cows in FTAI pregnancy rates between the 7&7 Synch (52.4%) and the 7-day CO-Synch+CIDR (44.9%) treatments. A greater (P=0.05) proportion of two-year-old cows were pregnant to FTAI following treatment with the 7-day CO-Synch+CIDR (56.7%) as compared to the 7&7 Synch (33.4%). A greater (P=0.02) proportion of two-year-old cows in the 7-day CO-Synch+CIDR treatment (91.9%) were pregnant at the conclusion of the breeding season as compared with the 7&7 Synch (69.7%).

PSXII-15 Evaluation of later timing of fixed-time artificial insemination for beef cows when using sex-sorted semen following the 7 & 7 Synch protocol

Abstract An experiment was designed to evaluate later timing of fixed-time artificial insemination (FTAI) with sex-sorted semen among postpartum beef cows following the 7 & 7 Synch protocol, with the hypothesis that later timing would result in increased pregnancy rates (P/AI) among cows that expressed estrus prior to FTAI. Beef cows (n = 414) were blocked based on age and days postpartum (DPP) and randomly assigned to receive FTAI at 66 or 72 h after administration of prostaglandin F2α (PG). Estrus was synchronized using the 7 & 7 Synch protocol, which consists of administration of PG (500 μg cloprostenol) and insertion of an intravaginal progesterone-releasing insert (CIDR; 1.38 g progesterone) on Day 0, gonadotropin-releasing hormone (GnRH; 100 μg gonadorelin) on Day 7, and PG coincident with CIDR removal on Day 14. Estrus detection aids (EstrotectTM) were applied to all cows on Day 14, and activation status was recorded at fixed-time artificial insemination (FTAI) on Day 17. All cows that expressed estrus prior to FTAI received sex-sorted semen (4 × 106 cells per unit; SexedULTRA 4MTM). The proportion of cows expressing estrus prior to FTAI did not differ between treatments at this power of test [66 h: 71% (146/205); 72 h: 76% (158/209)]. Additionally, P/AI of estrous cows inseminated with sex-sorted semen did not differ between treatments [66 h: 44% (90/205); 72 h: 39% (82/209)]. In conclusion, later timing of FTAI following the 7 & 7 Synch protocol failed to improve P/AI of estrous cows inseminated with sex-sorted semen.

PSXII-16 Fertility affects in yearling beef heifers grazing triticale before artificial insemination

Abstract Our objective was to compare two systems of pre-breeding heifer development, drylot (D) or grazing winter triticale (T) on heifer fertility. In each of 4 years (yr), Black Angus heifers (n = 168, 86, 97 and 103, respectively) were allotted to treatment (trt) 32 to 50 days (d) prior to artificial insemination (AI). Each year a 14-d CIDR PG protocol was used to synchronize estrus (d-30 to d-16: 1.38 g progesterone intravaginal insert, CIDR; d 0: 25 mg dinoprost tromethamine injection; + 66 hours: 100 µg gonadorelin hydrochloride injection, and AI). Starting body weight and body condition were similar between treatments but differed by year (P < 0.01). After CIDR removal, 83% were in estrus by d -10 and did not differ with trt or yr. Weight at AI was greater (P < 0.01) for T (384 kg ± 2) than D (378 kg ± 2) with a trt by yr interaction. Body condition change between start of treatment and AI was greater (P < 0.01) for T (0.44 ± 0.03) than D (-0.02 ± 0.04) with a trt by yr interaction (P < 0.01) due to the magnitude of difference. A trt by yr interaction occurred for estrous response before AI (P < 0.01). Treatment means for AIPR were 59.1% (143/242) for D and 42.1% (101/240) for T (trt; P < 0.01). AIPR was similar between treatments in yr 1 and higher for D than T in subsequent yr (trt x yr, P < 0.05). Blood urea nitrogen was greater (P < 0.05) in T than D on d 0 and at AI. At the time of AI, triticale was more mature in yr 1 when there was no difference in AIPR. Grazing triticale during estrus synchronization and AI resulted in acceptable gains but decreased fertility in yearling beef heifers.

519 Late-Breaking: Evaluation of the 7 & 7 Synch and Bee Synch II protocols for control of the estrous cycle among cows of varying percentage Bos indicus influence

Abstract The 7 & 7 Synch and Bee Synch II protocols for control of the estrous cycle were compared among cows with varying percentages of Bos indicus influence. Angus (n = 48), ⅛ - ¼ Brahman-influenced (n = 90), Brangus (n = 11), and ½ Brahman-influenced (n = 56) cows were blocked based on breed, age, and days postpartum and randomly assigned to treatment. Cows treated with 7 & 7 Synch (n = 104) received prostaglandin F2α (PG; 25 mg dinoprost tromethamine) and insertion of an intravaginal progesterone-releasing insert (CIDR; 1.38g progesterone) on Day -17, gonadotropin-releasing hormone (GnRH; 100 μg gonadorelin) on Day -10, and PG coincident with CIDR removal on Day -3. Cows treated with Bee Synch II (n = 101) received PG coincident with CIDR insertion on Day -8 and PG coincident with CIDR removal on Day -3. Fixed-time artificial insemination was performed on Day 0 at 66 h. Ovarian ultrasound was performed on Day -3 to assess presence of corpora lutea (CL) and diameter of the largest ovarian follicle (LFD), and color Doppler was used on Day 7 to assess CL blood perfusion. A greater proportion of 7 & 7 Synch cows (P < 0.0001) had CL on Day -3 (83%; 86/104) compared with Bee Synch II cows (48%; 48/101). On Day -3, LFD did not differ among Bos indicus-influenced cows treated with Bee Synch II (12.5±0.3 mm), Bos indicus-influenced cows treated with 7 & 7 Synch (12.2±0.3 mm), or Angus cows treated with 7 & 7 Synch (12.1±0.6 mm); however, greater LFD was observed among Angus cows treated with Bee Synch II (15.4±0.8 mm). Brangus cows had greater periphery signal percentages (P = 0.02) when treated with 7 & 7 Synch compared with Bee Synch II. In conclusion, across cow of varying percentage Bos indicus influence, 7 & 7 Synch resulted in a greater proportion of cows with CL on Day -3.

Effects of GnRH and hCG administration during early luteal phase on estrous cycle length, expression of estrus and fertility in lactating dairy cows

Our objective was to determine the effects of a single treatment of human chorionic gonadotropin (hCG) or GnRH from d 5 to 7 of the estrous cycle on cycle length, expression of estrus and fertility in lactating dairy cows. Lactating Holstein cows (n = 354) located in Farm 1 and lactating Jersey cows located in Farm 2 (n = 210) detected in estrus by an Automated Activity Monitor (AAM) system from 27 to 50 days in milk (DIM) were randomly assigned to receive one of three treatments from d 5 to 7 of the estrous cycle: control (untreated; CON; Holstein, n = 111; Jersey, n = 66), GnRH (86 μg gonadorelin acetate im; Holstein, n = 116; Jersey, n = 75), or hCG (3,300 IU im; Holstein, n = 127; Jersey, n = 69). Ovaries were scanned with ultrasound in a random subgroup of cows (Holstein/Farm 1, n = 147; Jersey/Farm 2, n = 94) on the day of treatment and 3 or 4 d later to determine ovulation. Estrus was detected after treatment by an AAM, and peak activity and heat index were recorded. A random subgroup of cows observed in estrus after treatment received first AI from 51 to 80 DIM (Holstein, n = 208; Jersey, n = 138). Pregnancy diagnoses were performed by transrectal ultrasonography at 37 ± 3 d post-AI. Holstein and Jersey cows treated with GnRH and hCG had an increased (P < 0.05) ovulatory response compared with controls. Human chorionic gonadotropin decreased (74%; P = 0.05) and GnRH tended to reduce (75%; P = 0.07) the proportion of multiparous Holstein cows returning to estrus compared with CON (86%). Cows treated with hCG had a longer (P < 0.01) estrous cycle length (24.6 ± 0.3 d, Holstein; 23.0 ± 0.3 d, Jersey) compared with CON cows (22.7 ± 0.3 d, Holstein; 21.3 ± 0.3 d Jersey) and GnRH (22.9 ± 0.3 d, Holstein; 21.1 ± 0.3 d Jersey). The percentage of cows with high (≥80) peak activity and heat index did not differ (P > 0.50) between treatments, and milk production did not affect (P > 0.65) the duration of estrus. Pregnancy per AI (P/AI) was not affected by treatments in Holstein (P = 0.93; CON: 34.3%, GnRH: 35.4%, and hCG: 31.5%) and in multiparous Jersey cows (P = 0.35; CON: 34.3%, GnRH: 35.4%, and hCG: 31.5%), but hCG had greater (P = 0.03; 55%) P/AI than GnRH (30.0%) and a trend (P = 0.06) for greater P/AI than CON (33.3%) in primiparous Jersey cows. In summary, inducing the formation of an accessory corpus luteum from d 5 to 7 of the estrous cycle with hCG reduced expression of estrus in multiparous Holstein cows. Moreover, hCG increased estrous cycle length in Holstein and Jersey cows, and it did not affect first service P/AI at 37 ± 3 d post-AI in Holstein and multiparous Jersey lactating cows. However, hCG increased P/AI in primiparous Jersey cows. Future research with a larger number of cows is needed to confirm these intriguing fertility results.

Evaluation of hormonal treatments for different scenarios of cystic ovarian follicles in dairy cattle

The present study aimed to evaluate the efficacy of different hormonal interventions in the treatment of cystic ovarian follicles (COF) based on different scenarios, including the size of the cyst and the presence of other follicles on the ovaries of dairy cows. A total of 199 Holstein cows with COF in the first 100 days postpartum were enrolled in the study. These cows were randomly assigned to the four following groups: 1) GnRH (G) group: intramuscular (IM) injections of 100 µg gonadorelin acetate on day 0 and 150 µg d-cloprostenol 7-12 days later, 2) double GnRH (DG) group: two IM injections of 100 µg gonadorelin acetate at 6 h intervals on day 0 and d-cloprostenol 7-12 days later, 3) intravaginal progesterone device (IPD) group: insertion of PRID Delta for 7-12 days and injection of d-cloprostenol on the withdrawal of PRID Delta, and 4) control group: IM injection of 2 mL sterile saline on day 0 and 7-12 days later. The cure rate of COF significantly improved in the G and DG groups, in comparison with the IPD and control groups. There was no significant difference between the cows in the G and DG groups. In the control group, animals with ovarian cysts smaller than 2.5 cm had a significantly greater self-cure rate, compared to the other cows. In conclusion, this field study demonstrated a good clinical cure in the groups of cows treated by GnRH. However, no improvement was observed in the reproductive performance of these animals.

Pengaruh Pemberian GnRH pada Sapi Potong yang Mengalami Kawin Berulang (Repeat Breeding)

Repeat breeding is a condition in which cows have normal estrous cycles and have been mated 3 times or more but are not pregnant. The incidence of repeat breeding in beef cattle can be detrimental to breeders in terms of time, that the calving period becomes longer so that the cows cannot give birth to calves once a year. Various ways to deal with repeat breeding have been done, but the results are not optimal. This study was conducted to determine the effect of Gonadotrophin Releasing Hormone (GnRH) in cows with repeat breeding. A total of fifteen beef cattle with repeat breeding were used in this study. The cows were divided into 3 groups of 5 each. Cows that were estrus in the first group (as a control group) were only performed artificial insemination (AI) without GnRH injection. In the second and third groups, after AI, they were injected with GnRH at AI time and 3-4 days after AI with a dose of 5 ml (Fertagyl®, 500 µg gonadorelin) intramuscularly. A pregnancy examination was carried out three months later and the results were recorded. The data obtained were analyzed descriptively and quantitatively using Chi-Square statistical analysis. The results of the analysis showed that there were differences in the pregnancy rate in the first group (control) with the second cow group and the third cow group, which were 20%, 80%, and 60% respectively. Based on statistical analysis, there was a significant difference in pregnancy rate (P &lt;0.05) between the three groups. It was concluded that GnRH administration could increase the pregnancy rate in beef cattle that had repeat breeding.

Birth of a Live Cria After Transfer of a Vitrified-Warmed Alpaca (Vicugna pacos) Preimplantation Embryo.

The alpaca (Vicugna pacos) is an important species for the production of fiber and food. Genetic improvement programs for alpacas have been hindered, however, by the lack of field-practical techniques for artificial insemination and embryo transfer. In particular, successful techniques for the cryopreservation of alpaca preimplantation embryos have not been reported previously. The objective of this study was to develop a field-practical and efficacious technique for cryopreservation of alpaca preimplantation embryos using a modification of a vitrification protocol originally devised for horses and adapted for dromedary camels. Four naturally cycling non-superovulated Huacaya females serving as embryo donors were mated to males of proven fertility. Donors received 30 μg of gonadorelin at the time of breeding, and embryos were non-surgically recovered 7 days after mating. Recovered embryos (n = 4) were placed individually through a series of three vitrification solutions at 20°C (VS1: 1.4 M glycerol; VS2: 1.4 M glycerol + 3.6 M ethylene glycol; VS3: 3.4 M glycerol + 4.6 M ethylene glycol) before loading into an open-pulled straw (OPS) and plunging directly into liquid nitrogen for storage. At warming, each individual embryo was sequentially placed through warming solutions (WS1: 0.5 M galactose at 37°C; WS2: 0.25 M galactose at 20°C), and warmed embryos were incubated at 37°C in 5% CO2 in humidified air for 20–22 h in 1 ml Syngro® holding medium supplemented with 10% (v/v) alpaca serum to perform an initial in vitro assessment of post-warming viability. Embryos whose diameter increased during culture (n = 2) were transferred individually into synchronous recipients, whereas embryos that did not grow (n = 2) were transferred together into a single recipient to perform an in vivo assessment of post-warming viability. Initial pregnancy detection was performed ultrasonographically 29 days post-transfer when fetal heartbeat could be detected, and one of three recipients was pregnant (25% embryo survival rate). On November 13, 2019, the one pregnant recipient delivered what is believed to be the world's first cria produced from a vitrified-warmed alpaca embryo.

141 Effect of induction of an ipsilateral vs. contralateral accessory corpus luteum (CL) on pregnancy per AI and pregnancy loss in lactating dairy cows

Abstract Induction of accessory CL can increase circulating progesterone (P4) and potentially improve fertility; although, regression of accessory CL contralateral to the pregnancy can occur, potentially negating their benefit. In this study, primiparous (n = 377) and multiparous (n = 678) lactating Holstein cows (80.0 ± 3.3DIM, 43.2 ± 13.3 kg milk/d, and BCS = 2.85 ± 0.24) were enrolled in Presynch-Ovsynch (PGF-14d-PGF-12d-GnRH-7d-PGF-56h-GnRH-16h-AI) with AI at 81 ± 3 DIM. On d5 after AI, cows were randomly but unequally assigned as Control (n = 289) or GnRH (n = 641; 100 µg gonadorelin acetate). Blood samples were collected for P4 and ovaries evaluated by ultrasound on d5, d12, d19, d26, d33, d47, and d61. mRNA for ISGs (d19) and PSPB (d26) concentrations were evaluated and pregnancy diagnoses were done on d26, d33, d47 (also embryonic measurements), and d61. Statistical analyses were performed with PROC GLIMMIX of SAS 9.4. Ovulation to GnRH on d5 was 85.4% (577/676). Cows were designated as: Control (n = 289), Ipsilateral (n = 239), or Contralateral (n = 241). Overall P4 differed (P &amp;lt; 0.01) within groups (Control = 7.90 ± 0.35c, Ipsilateral = 10.5 ± 0.34a, and Contralateral = 9.55 ± 0.26a). Interestingly, 52.7% (78/148) of contralateral pregnant cows had accessory CL regression by d61 with decreases in P4 after contralateral CL regression (P &amp;lt; 0.001). There were no treatment differences for pregnant cows in ISG15 (P = 0.63) or Mx2 (P = 0.51) mRNA, circulating PSPB (P = 0.56), amniotic vesicle size (P = 0.89), or crown-rump length (P = 0.19) or in pregnancy/AI on d26 (P = 0.24), d33 (P = 0.67), d47 (P = 0.53), or d61 (P = 0.62; overall 50.3% [387/769]). Nevertheless, pregnancy losses between d26 and d61 were lower (P = 0.03) for ipsilateral (6.6 ± 2.3%) than contralateral (14.0 ± 3.0%) and from controls (P = 0.065; 13.7 ± 2.9%) With differences also from d26-33 (Control = 7.5 ± 2.1; Ipsilateral = 3.1 ± 1.5; Contralateral = 9.6 ± 2.5). Within contralateral group, early accessory CL regression was associated with greater pregnancy loss from d26-33 (P = 0.04) and d26-61 (P = 0.01). Thus, induction of accessory CL increases P4 and may reduce pregnancy loss, although these advantages are reduced for contralateral accessory CL, because many of these CL regress during pregnancy.

Evaluation of later timepoints for split-time artificial insemination when using sex-sorted semen among beef heifers following the 14-d CIDR®-PG protocol

An experiment was designed to evaluate later timepoints for Split-Time AI (STAI), with the hypothesis that delaying AI may improve estrous response and pregnancy per AI when using sex-sorted semen. Timing of estrus was synchronized among 794 heifers using the 14-d CIDR®-PG protocol (1.38 g progesterone intravaginal insert from Day 0–14, followed by 25 mg dinoprost tromethamine on Day 30) with STAI performed based on estrous status. Heifers were blocked based on breed, source, sire, reproductive tract score (RTS), and BW and assigned within block to one of two approaches. In Approach 66, heifers that were estrual by 66 h after PG administration were inseminated at 66 h, and remaining heifers were inseminated 24 h later (90 h). In Approach 72, heifers that were estrual by 72 h were inseminated at 72 h, and remaining heifers were inseminated 24 h later (96 h). With both approaches, heifers that were non-estrual by the final timepoint were administered 100 μg gonadorelin acetate (GnRH). Within approach, heifers were pre-assigned to receive SexedULTRA 4M™ sex-sorted or conventional semen. The proportion of heifers estrual by the first timepoint was greater (P < 0.0001) with Approach 72 (76 %; 302/395) compared to Approach 66 (61 %; 242/399). The proportion of heifers pregnant as a result of AI differed (P = 0.0005) by semen type (59 % [240/404] for conventional compared with 48 % [187/390] for sex-sorted) but was not affected by approach or approach × semen type. In summary, pregnancy per AI of heifers receiving sex-sorted or conventional semen following the 14-d CIDR®-PG protocol did not differ when STAI was delayed 6 h. The proportion of estrual heifers prior to the first timepoint, however, was greater with later STAI.

Comparison of the 7 & 7 Synch protocol and the 7-day CO-Synch + CIDR protocol among recipient beef cows in an embryo transfer program

An experiment was designed to evaluate the effectiveness of the recently developed 7 & 7 Synch protocol to synchronize estrus among recipients prior to embryo transfer (ET). Postpartum beef cows (n = 1358) across thirteen locations were assigned to either the 7-d CO-Synch + CIDR protocol or the 7 & 7 Synch protocol prior to ET. Cows were preassigned to balanced treatments within location based on age and days postpartum, with body condition score recorded at ET. Cows assigned to the 7-d CO-Synch + CIDR protocol were administered gonadotropin-releasing hormone (GnRH; 100 μg gonadorelin acetate) on Day 7, an intravaginal controlled internal drug release (CIDR; 1.38 g progesterone) from Day 7 to Day 14, and prostaglandin F2α (PGF2α; 25 mg dinoprost tromethamine) coincident with CIDR removal on Day 14. Cows assigned to the 7 & 7 Synch protocol were administered PGF2α (25 mg dinoprost tromethamine) coincident with CIDR insertion on Day 0, GnRH (100 μg gonadorelin acetate) on Day 7, and PGF2α (25 mg dinoprost tromethamine) coincident with CIDR removal on Day 14. Cows were observed for visible signs of estrus, with GnRH (100 μg gonadorelin acetate) administered to cows failing to express estrus during the detection period. Embryo transfer was performed approximately seven days after estrus or GnRH administration. Presence of corpora lutea (CL) was determined via transrectal palpation by a single veterinarian blinded to treatment, and embryos were transferred only to cows with palpable CL. Embryo transfer was performed using either fresh or frozen embryos, with embryo stage and grade recorded for each recipient. The proportion of cows expressing estrus was increased (P < 0.0001) among cows assigned to the 7 & 7 Synch protocol (86% [529/615] vs 76% [488/640]). The proportion of cows expressing estrus and presenting with palpable CL at ET was greater (P < 0.0001) among cows following treatment with the 7 & 7 Synch protocol compared to the 7-d CO-Synch + CIDR protocol (76% [466/615] vs 65% [418/640]). Consequently, the proportion pregnant to ET was greater (P < 0.03) following the 7 & 7 Synch protocol (40% [263/653]) compared to the 7-d CO-Synch + CIDR protocol (34% [228/664]). In summary, the 7 & 7 Synch protocol involving administration of PGF2α and treatment with a CIDR for 7 days prior to GnRH improved the likelihood of estrus expression in recipients, increased the proportion of cows eligible to receive an embryo, which resulted in a greater pregnancy rate to ET.

Treatment with prostaglandin F2α and an intravaginal progesterone insert promotes follicular maturity in advance of gonadotropin-releasing hormone among postpartum beef cows

An experiment was designed to evaluate treatments to promote ovarian follicular maturity in advance of administration of exogenous gonadotropin-releasing hormone (GnRH; 100 μg gonadorelin) for control of the bovine estrous cycle. We hypothesized prostaglandin F2α (PGF2α; 500 μg cloprostenol) followed by an intravaginal progesterone-releasing insert (CIDR; 1.38 g progesterone) would induce greater follicle size and serum estradiol at the time of GnRH administration. Postpartum cows (n = 194) in two locations were assigned to one of five treatments based on age, days postpartum, and body condition score. Cows in Treatment 1 were treated with the standard 7-d CO-Synch + CIDR protocol: administration of GnRH and CIDR insertion on Day −10, and administration of PGF2α and CIDR removal on Day −3. Treatments 2–5 were designed in a 2 × 2 factorial arrangement, with Treatment 1 included as an additional reference. On Day −17, cows in Treatments 2–5 received a CIDR insert, either with (Treatments 2 and 3) or without (Treatments 4 and 5) administration of PGF2α at CIDR insertion. On Day −10, all cows were administered GnRH, and CIDR inserts were either removed (Treatments 2 and 4) or remained in place until Day −3 (Treatments 3 and 5). Treatment with PGF2α and CIDR in advance of GnRH (Treatments 2 and 3) resulted in increased diameter of the largest ovarian follicle (P < 0.001) and increased serum concentrations of estradiol (P < 0.0005) on Day −10. In addition, variation among cows in CL status (no CL vs. a single CL vs. multiple CL) on Day −3 tended to be decreased (P = 0.08), with cows more likely to have a single CL rather than no CL or multiple CL. Lastly, the proportion of cows expressing estrus prior to fixed-time artificial insemination tended (P = 0.08) to be improved. Results support the hypothesis that administration of PGF2α and treatment with a CIDR for 7 days prior to GnRH promotes follicular maturity in advance of GnRH administration and may provide an approach by which to enhance response of postpartum beef cows to GnRH-based estrus synchronization programs.

Effect of two prostaglandin F2α injections administered 24 hours apart on the pregnancy rate of Simmental cows subjected to the Ovsynch or Ovsynch + Controlled internal drug release (CIDR) protocols

The aim of the present study was to determine the effects of one or two doses of prostaglandin F2α (PGF) on the pregnancy rate (PR) in Simmental cows subjected to the Ovsynch or Ovsynch + Controlled internal drug release (CIDR) protocols. On d 0, 100 µg gonadorelin diacetate tetrahydrate (GnRH) was injected into cows in group 1 (n = 50) and group 2 (n = 40) and CIDR was intravaginally inserted. On d 7, 25 mg dinoprost tromethamine (PGF2α, PGF) was administered, and GnRH was injected 56 h later. Fixed-time artificial insemination (TAI) was performed 16 h after GnRH injection. In group 3 (n = 62) and group 4 (n = 63), PGF was administered 7 d following GnRH treatment, and GnRH was injected 56 h later. TAI was performed 16 h after GnRH injection. In groups 2 and 4, a second dose of PGF was injected 24 h after the first dose. Pregnancy was determined by transrectal ultrasonography on d 30 and 60 post-TAI. The pregnancy rate (PR) on d 30 post-TAI was significantly different among the groups: 46%, 55%, 29%, and 36.5%, in groups 1, 2, 3, and 4, respectively (P = 0.048). In addition, the PR was 36.3% and 43.7% in the single PGF and double PGF injection groups, respectively. There was no statistical difference in the PR on d 60 post-TAI (P &gt; 0.05). Pregnancy loss was between 4.34% and 11.11% (P &gt; 0.05). The highest PR in the primiparous cows was observed in group 3 (57.7%). The PR was not significantly different among multiparous cows (P &gt; 0.05). In conclusion, two injections of PGF administered 24 h apart in Simmental cows may increase the PR in the Ovsynch or Ovsynch + CIDR protocols.

PSXIII-12 Evaluation of split-time artificial insemination following administration of the 7-d CO-Synch + CIDR® estrus synchronization protocol in beef heifers

Abstract Estrous response and pregnancy rates resulting from fixed-time (FTAI) or split-time (STAI) artificial insemination were compared among heifers following treatment with the 7-d CO-Synch + CIDR® (controlled internal drug release;1.38g progesterone) protocol. Heifers (n = 456) were assigned to balanced treatments based on weight and reproductive tract score (RTS; Scale 1–5). Gonadotropin-releasing hormone (GnRH; 100 µg gonadorelin acetate) was administered coincident with CIDR® insertion. Progesterone inserts were removed after 7 d, and PG (250 mg im cloprostenol sodium) was administered at CIDR® removal. Estrus detection aids (Estrotect®) were applied at the time PG was administered. Estrous status was recorded at FTAI or STAI, and estrus was defined as removal of ≥ 50% of the grey coating from the Estrotect® patch. Heifers assigned to the FTAI treatment received GnRH and were artificially inseminated 54 h after PG administration. In the STAI treatment, only heifers that expressed estrus prior to 54 h were artificially inseminated at that time. For heifers failing to express estrus, AI was postponed 24 h and only those heifers that failed to exhibit estrus by the delayed time (78 h) received GnRH concurrent with AI. Estrous response prior to the standard time of FTAI did not differ between treatments (P = 0.3). Total estrous response was increased (P &amp;lt; 0.001) among heifers assigned to STAI (74%, STAI; 47%, FTAI); however, pregnancy rates resulting from AI were similar between treatments (48%, STAI; 46%, FTAI; P = 0.4), as were pregnancy rates at the end of a 60 d breeding season (P = 0.6). In summary, STAI resulted in a greater estrous response following treatment with the 7-d CO-Synch + CIDR® protocol; however, this did not result in an increase in pregnancy rate compared to heifers that received FTAI.

Postovulatory treatment with GnRH on day 5 reduces pregnancy loss in recipients receiving an in vitro produced expanded blastocyst

The present study tested the hypothesis that administration of GnRH on day 5 of the estrous cycle in embryo transfer (ET) recipients would increase progesterone (P4) concentrations, embryo size, and improve fertility. Holstein and cross-bred Holstein heifers (n = 1562) were synchronized using a modified 5-day CIDR-Synch protocol as follows (All AM treatments): D-8, CIDR inserted; D-3, CIDR removed and PGF2α (500 μg cloprostenol) treatment; D-2, second PGF2α; D0, GnRH (G1, 100 μg gonadorelin acetate) to induce ovulation. On D5 in the afternoon, heifers were assigned in a completely randomized design to one of two treatments: Control (untreated) or GnRH (200 μg). Transfer of day 7 fresh IVP embryos was performed between D6 and D8 after G1. Data collected from each heifer included: embryo stage and quality, body condition score, technician performing ET, interval from G1 to ET, and number of previous transfers. All heifers were evaluated by transrectal ultrasonography on D5, D33, and D60 and a subset of heifers was scanned on D12 (n = 718; to determine ovulation to treatment) and another subset on D33 (n = 295; 16 s video to determine embryo and amniotic vesicle size). Serum P4 was determined from a subset of heifers on D12 (n = 467) and on D21 (n = 837) and pregnancy specific protein B (PSPB) on D28 (n = 843). Pregnancies per ET (P/ET) were analyzed by logistic regression and continuous outcomes by ANOVA. Ovulation to D5 GnRH, defined by the presence of an accessory CL on D12, was 83.9% (302/360) in GnRH-treated heifers vs. 3.3% (12/358) in Controls (P < 0.001). On D12, P4 was greater (P < 0.001) in GnRH-treated heifers (7.2 ± 0.1 ng/ml) vs Controls (6.0 ± 0.1 ng/ml). There was greater P/ET at D33 and D60 of pregnancy for Stage 7 than Stage 6 embryos. Treatment with GnRH did not alter P/ET with either embryo stage but decreased pregnancy loss between D33 and D60 in heifers receiving Stage 7 embryos. Presence of an accessory CL at the D33 pregnancy diagnosis was associated with a larger reduction in pregnancy loss from D33 to D60 in recipients of Stage 7 embryos (11.6 vs 27.6%). Although there was no GnRH effect on embryo size, the presence of an accessory CL was associated (P < 0.05) with larger amniotic vesicle volume in recipients of Stage 7 embryos. In addition, greater PSPB was linked to greater amniotic vesicle volume (P = 0.01) and to reduced pregnancy loss (P < 0.0001). In conclusion, treatment with GnRH on D5 caused ovulation and formation of an accessory CL, increased circulating P4, and reduced pregnancy loss in heifers receiving a Stage 7 but not a Stage 6 IVP embryo.

Evaluation of split-time artificial insemination following administration of a long or short-term progestin-based estrus synchronization protocol in beef heifers

Fixed-time and split-time AI were compared following the melengestrol acetate (MGA®) prostaglandin F2α (Experiment 1) and 7-d CO-Synch + controlled internal drug release (CIDR®) protocols (Experiment 2). Heifers in Experiments 1 (n = 524) and 2 (n = 456) were assigned within pen to balanced treatments based on weight and reproductive tract score (RTS; Scale 1–5). In Experiment 1, MGA® (0.5 mg∙animal−1∙d−1) was fed for 14 d, and prostaglandin F2α (PG; 250 μg im cloprostenol sodium) was administered 19 d after MGA® withdrawal. In Experiment 2, gonadotropin-releasing hormone (GnRH; 100 μg gonadorelin acetate) was administered coincident with CIDR® (1.38 g progesterone [P4]) insertion. Inserts were removed after 7 d, and PG (250 μg im cloprostenol sodium) was administered at CIDR® removal. In both experiments, estrus detection aids (Estrotect®) were applied at the time of PG administration. Estrous status was recorded at FTAI or STAI. Estrus was defined as removal of ≥ 50% of the grey coating from the Estrotect® patch. Heifers assigned to FTAI treatments received GnRH and were artificially inseminated at the standard time for FTAI for each protocol: 72 or 54 h after PG administration for the MGA-PG or 7-d CO-Synch + CIDR® protocol, respectively. In the STAI treatments, only heifers that expressed estrus prior to the standard time of FTAI were artificially inseminated at that time. For heifers failing to express estrus, AI was postponed 24 h. Only heifers that failed to exhibit estrus by the delayed time received GnRH concurrent with AI. In both experiments, estrous response prior to the standard time of FTAI did not differ between treatments. Total estrous response was increased (P < 0.01) among heifers assigned to STAI in Experiment 1 (88%, STAI; 72%, FTAI) and 2 (74%, STAI; 47%, FTAI). In Experiment 1, pregnancy rates resulting from AI were greater (P < 0.04) for heifers assigned to STAI compared with FTAI (55% vs 46%, respectively). In Experiment 2, pregnancy rates resulting from AI were similar between treatments (48% and 46%, respectively; P = 0.6). In summary, when compared with FTAI, STAI resulted in greater estrous response following both the MGA®-PG and 7-d CO-Synch + CIDR® protocols. The increased estrous response through use of STAI was associated with a corresponding increase in pregnancy rates to AI following the MGA®-PG protocol; however, a similar improvement in pregnancy rates was not observed following the 7-d CO-Synch + CIDR® protocol.